API Manufacturing Support

Access to the Market. Fast and Safe.

In order to accelerate your access to the market, we have state-of-the-art infrastructures to develop and produce bulks of Active Pharmaceutical Ingredients intended for use in humans.

Once your process is optimized, and during technology transfer, Univercells can supply globally quantities of APIs to support your short term clinical trials (phase 1, 2 & 3) and your long term commercialization.


What type(s) of biologics have you experience with?

Univercells has experience with a wide variety of cell lines and biologics. Our leading scientists have actively participated in the development of several industrial processes for vaccines, both human and veterinary, and recombinant proteins including monoclonal antibodies and enzymes. Our large expertise of the field allowed us to develop robust and validated processes which will allow us to fast-track your biomanufacturing process development and industrialization.